📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Favrille

1.1 - Company Overview

Favrille Logo

Favrille

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of targeted immunotherapies, focused on research, development and commercialization for the treatment of cancer and other diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Favrille

Fennec Pharmaceuticals Logo

Fennec Pharmaceuticals

HQ: United States Website
  • Description: Provider of a sodium thiosulfate treatment to prevent hearing loss in children undergoing chemotherapy; a small-stage biotechnology company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fennec Pharmaceuticals company profile →
Forbius Logo

Forbius

HQ: United States Website
  • Description: Provider of clinical-stage biotherapeutics for the treatment of cancer and fibrotic diseases, developing agents that target the transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forbius company profile →
Zap Surgical Logo

Zap Surgical

HQ: United States Website
  • Description: Provider of the ZAP-X gyroscopic radiosurgery platform for treating brain tumors, lesions, and head and neck conditions, utilizing a modern linear accelerator that eliminates radioactive source replacements. Offers vault-free design to reduce infrastructure costs, dual independent gantries for >1000 non-coplanar beam angles, tungsten-shielded collimation, and SRS webinars and clinical publications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zap Surgical company profile →
Forty Seven Logo

Forty Seven

HQ: United States Website
  • Description: Provider of clinical-stage immuno-oncology therapies targeting cancer immune evasion pathways, based on technology licensed from Stanford University. Lead program 5F9 is a monoclonal antibody against the CD47 receptor, a 'don't eat me' signal that cancer cells commandeer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Forty Seven company profile →
Synimmune Logo

Synimmune

HQ: Germany Website
  • Description: Provider of innovative mono- and bispecific anti-tumor antibodies for treating life-threatening diseases, focusing on orphan hematopoietic malignancies; lead product candidate is the antibody FLYSYN.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synimmune company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Favrille

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Favrille

2.2 - Growth funds investing in similar companies to Favrille

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Favrille

4.2 - Public trading comparable groups for Favrille

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Favrille

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Favrille

What does Favrille do?

Favrille is a provider of targeted immunotherapies, focused on research, development and commercialization for the treatment of cancer and other diseases.

Who are Favrille's competitors?

Favrille's competitors and similar companies include Fennec Pharmaceuticals, Forbius, Zap Surgical, Forty Seven, and Synimmune.

Where is Favrille headquartered?

Favrille is headquartered in United States.

How many employees does Favrille have?

Favrille has 1,000 employees 🔒.

When was Favrille founded?

Favrille was founded in 2010 🔒.

What sector and industry vertical is Favrille in?

Favrille is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Favrille

Who are the top strategic acquirers in Favrille's sector and industry

Top strategic M&A buyers and acquirers in Favrille's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Favrille?

Top strategic M&A buyers groups and sectors for Favrille include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Favrille's sector and industry vertical

Which are the top PE firms investing in Favrille's sector and industry vertical?

Top PE firms investing in Favrille's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Favrille's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Favrille's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Favrille's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Favrille include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Favrille's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Favrille?

The key public trading comparables and valuation benchmarks for Favrille include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Favrille for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Favrille with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Favrille's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Favrille with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Favrille's' sector and industry vertical?

Access recent funding rounds and capital raises in Favrille's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Favrille